Tech Nuggets with the Technology: Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)

Tuesday, February 4, 2020

Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital (Kyle Wiggers/VentureBeat)

Kyle Wiggers / VentureBeat:
Toronto-based BenchSci, which is using AI to accelerate drug discovery research and reduce related costs, raises $22M Series B led by F-Prime Capital — Assessing the health of pharmaceutical R&D by unearthing hidden patterns in procurement data is a task made simpler by AI.

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)